Hokanson J

Yale University School of Medicine, New Haven, CT, USA.

8 papers · 3 preprints

ArticlePsychedelics

A Multi-Site Evaluation of a Psychedelic Medicine Curriculum for Psychiatry Trainees.

Yaden ME, O'Donnell KC, Roberts DE +10

Europe PMC2026
ArticlePsilocybin

Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD.

Shnayder S, Agin-Liebes G, Hubert TJ +5

Europe PMC2026
ArticlePsilocybin

Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD.

Agin-Liebes G, Shnayder S, Fram G +6

Europe PMC2026
PreprintPsilocybin

Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD

Shnayder S, Agin-Liebes G, Hubert T +5

Europe PMC2026
PreprintPsilocybin

Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial

Kelmendi B, Adams T, Ching THW +16

Europe PMC2026
ArticlePsilocybin

Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.

Ching THW, Stahnke B, Shnayder S +22

Europe PMC2025
ArticlePsilocybin

Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.

Rajwani K, Jacobs E, Bruce L +10

Europe PMC2025
PreprintPsilocybin

Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies

Rajwani K, Almonte MT, Feroz F +6

Europe PMC2025
ArticlePsilocybin

Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.

Ching THW, Amoroso L, Bohner C +16

Europe PMC2024
ArticlePsilocybin

Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.

Ching THW, Amoroso L, Bohner C +15

Europe PMC2023
ArticlePsilocybin

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.

Ching THW, Grazioplene R, Bohner C +14

Europe PMC2023